2.3
2022

Fatal asthma after omalizumab and controller therapy

Show more: Authors information and Publication history
Authors Information

1 Unità Dipartimentale di Allergologia-Immunologia Clinica e Malattie Apparato Respiratorio, Ente Ospedaliero Fondazione Poliambulanza, Brescia, Italy
2 National Healthcare System, private practice, Bergamo, Italy
3 Allergy and Respiratory Diseases, University of Genoa, Genova, Italy

History

:
Published online: 23 July 2018
Accepted: 20 June 2018
Received: 4 November 2018

KEY WORDS
fatal asthma; omalizumab; alternaria; controller drug; discontinuation

Table of Content: Vol. 50 (No. 5) 2018 September

European Annals of Allergy and Clinical Immunology ISSN 1764-1489 | © 2024